(11:02 GMT) Crinetics Pharmaceuticals Price Target Raised to $85.00/Share From $62.00 by Baird
Dow Jones Newswires
Crinetics Pharmaceuticals Is Maintained at Outperform by Baird
- Sources
- Dow Jones Newswires
- Markets
- Stocks
- Active symbols
- NASDAQ:CRNX
- Language
- English (India)